MiniMed Completes Separation from Medtronic, Becomes Independent Company

MiniMed Group, Inc. announced the successful completion of its separation from Medtronic plc, effective October 15, 2026. The separation was finalized through an exchange offer, establishing MiniMed as a fully independent, publicly traded company. As a result, Medtronic no longer holds any equity stake in MiniMed.

Key Details

• Exchange Offer: Medtronic exchanged 252,813,348 shares of MiniMed common stock for 55,032,401 of its own ordinary shares tendered by its shareholders.
• Board of Directors Update: Concurrent with the separation, four directors resigned, and Amy Bricker, Executive Vice President of Walgreen Co., was appointed to the Board. The Board size was reduced from 11 to eight members.
• Effective Date: The separation and all related board changes were effective as of October 15, 2026.